Ontology highlight
ABSTRACT:
INSTRUMENT(S):
ORGANISM(S): Homo Sapiens (human)
TISSUE(S): Permanent Cell Line Cell, Cell Culture
DISEASE(S): Renal Cell Carcinoma
SUBMITTER: Wei Chang
LAB HEAD: Zhongjin Yue
PROVIDER: PXD059160 | Pride | 2025-07-28
REPOSITORIES: Pride
Action | DRS | |||
---|---|---|---|---|
Original_data.rar | Other | |||
SEARCH.rar | Other | |||
checksum.txt | Txt |
Items per page: 1 - 3 of 3 |
Scientific reports 20250719 1
Acquired and intrinsic resistance to sunitinib is a major obstacle to improving the therapeutic efficacy of treatment for clear cell renal cell carcinoma (ccRCC). This study aimed to identify novel therapeutic targets and the potential molecular mechanisms to overcome sunitinib resistance in ccRCC. Utilizing genome-wide CRISPR/Cas9 screening and resistant transcriptomics, we identified that prostaglandin reductase 2 (PTGR2) is a novel therapeutic target to overcome sunitinib resistance in ccRCC. ...[more]